| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 181.40M | 185.20M | 184.30M | 174.20M | 132.90M |
| Gross Profit | 109.80M | 122.10M | 126.20M | 116.60M | 86.70M |
| EBITDA | -85.30M | 38.50M | -157.10M | 97.40M | 70.10M |
| Net Income | -120.30M | 5.40M | -192.50M | -37.80M | 123.90M |
Balance Sheet | |||||
| Total Assets | 2.21B | 2.47B | 2.53B | 2.84B | 2.51B |
| Cash, Cash Equivalents and Short-Term Investments | 10.50M | 25.30M | 11.60M | 18.50M | 49.00M |
| Total Debt | 793.10M | 876.00M | 889.50M | 943.60M | 626.50M |
| Total Liabilities | 881.90M | 968.30M | 982.50M | 1.05B | 712.30M |
| Stockholders Equity | 1.33B | 1.50B | 1.55B | 1.79B | 1.80B |
Cash Flow | |||||
| Free Cash Flow | 60.20M | 15.50M | 51.90M | 74.90M | 56.70M |
| Operating Cash Flow | 60.80M | 76.60M | 53.90M | 78.80M | 57.90M |
| Investing Cash Flow | 58.10M | 16.50M | 45.90M | -200.20M | 9.20M |
| Financing Cash Flow | -141.10M | -72.00M | -106.70M | 90.90M | -209.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £4.11B | 8.87 | 7.73% | 5.85% | 15.13% | 29.40% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £1.30B | 8.39 | 7.41% | 2.52% | 24.37% | 29.61% | |
63 Neutral | £2.12B | 13.23 | 4.48% | 3.93% | 39.97% | 39.03% | |
56 Neutral | £667.90M | -5.55 | -8.83% | 7.31% | -2.05% | -2319.15% | |
51 Neutral | £234.34M | 41.49 | 1.34% | 2.71% | 4.03% | -79.67% | |
42 Neutral | £1.76B | 133.42 | -5.79% | 0.36% | -2.90% | -2.16% |